Saturday, December 28, 2013

Comment Regarding Office Use under DQSA: 503A v. 503B--Are State Boards of Pharmacy Paying Attention!

1 comment:

Kenneth Woliner, MD said...
So, as I read this, any physician (or hospital) who wants to obtain compounded medications for "office use" (i.e. - no patient-specific prescription before the drug is ordered) - needs to buy it from an OUTSOURCING FACILITY. No if's and's or but's.

I hope state boards of medicine and boards of pharmacy are listening.

Kenneth Woliner, MD
www.holisticfamilymed.com

-------
Q: Under the new law, does a pharmacy wishing to compound a sterile non-patient specific product have to register under 503B?
A: Exact quote from Jane Axelrad:
“Section 503A was not changed by the new law and patient specific prescriptions are required under Section 503A. As you know, as you observe, 503B provides a pathway in which hospitals and health care professionals can purchase compounded drugs without prescriptions.”
Q: Only under 503B can you provide non-patient specific product?
A: Exact quote from Jane Axelrad: “If you want to qualify for the exemption under 503A.”

Florida DOH v. John Foster, MD (solutions pharmacy acted as an unlicensed wholesaler for compounded SottoPelle BHRT pellets)


The doctor only got a "letter of concern" and a $5,000 fine. 


1  record(s) found.
NameLicenseProfessionCityStateCase #Action Taken
FOSTER, JOHN DAVID42368Medical DoctorATLANTIC BEACHFL201010461Obligation(s) Satisfied
Thank you to Dr. Kenneth Woliner for the research and information.

PA Disciplined for implanted compounded bHRT pellets

You will want to read this disciplinary action found here.  Below is a summary provided by Dr. Kenneth Woliner of the case:

This physician assistant basically "played doctor" by "renting a MD supervising physician (who never showed up to "Millennium Medical Spa" which she owned)" by paying him $500/month (even though he never showed up). She implanted compounded bHRT pellets (specifically SottoPelle, made by "Solutions Pharmacy" of Chatenooga, TN)

Inserting pellets under local anesthesia is considered "surgery", and this physician assistant was clearly practicing beyond scope. Regardless, the patient was majorly overdosed on these hormones, having testosterone levels as high as a man. The patient didn't get a call back from the PA for a few days, then had a medication called in under the supervising physician's name (without his knowledge), and when the patient continued to have adverse effects and was rebuffed when she tried to speak to the non-existent MD, she went to her OB/GYN for treatment. Old records obtained including a falsified consent for procedure form. This is BAD.  (As an aside, the supervising physician, David Larkin, MD, got his license revoked in 2008 for aiding the unlicensed practice of medicine in his hair transplant business.)


United States v. FVS Holdings Inc d/b/a Green Valley Drugs: Update on Litigation--Motions Pending

Reminder: The US Attorney's Office Filed a Civil Complaint Against Green Valley Drugs

see blog here

2013 FVS Holdings, Inc. dba. Green Valley Drugs 8/30/13 Warning Letter from FDA

2013 FVS Holdings, Inc. dba. Green Valley Drugs 8/30/13

Advocates Urge Congress to Boost FDA’s Fiscal 2014 Funding

With the FDA set to tackle a host of new responsibilities, Congress should boost the agency’s fiscal 2014 funding to help it carry out its expanded mission, advocates for the FDA say. Read More

Nevada Compounder Green Valley Drugs Warned for Aseptic Practices Following April Recall


December 24, 2013
Nevada-based Green Valley Drugs, which recalled all of its sterile compounded products in April, has been warned by the FDA for a lack of sterility assurance and general quality control. Read More

Indian Hospira Plant Gets Form 483 With 23 Observations


December 27, 2013
The FDA has hit Hospira with a new Form 483 containing 23 observations after a return visit to its Irungattukottai, India, plant. Read More

December 28, 2013 Area attorney applauds fund for meningitis victims BY ANNE STANTON astanton@record-eagle.com


TRAVERSE CITY — A Traverse City attorney who represents dozens of clients who have suffered or died from tainted steroid injections welcomed the announcement of a $100 million-plus fund to compensate victims.
“I am encouraged by how quickly this came out,” said Traverse City attorney Mark Dancer.
continue to read here